Search results for "Cardiovascula."

showing 10 items of 8662 documents

El impacto de la inmunosupresión precoz en las complicaciones no asociadas al injerto hepático

2018

La falta de mejora a largo plazo de los resultados post-TH se debe en gran medida a complicaciones no asociadas al injerto en principio muy relacionadas con la exposición crónica a IS. En diferentes estudios se ha demostrado como la minimización de los ICN tiene un efecto protector en términos de toxicidad renal, metabólica, cardíaca y oncogénica. Sin embargo, no existe una evidencia sólida sobre el impacto que pueda tener la IS precoz, es decir aquella administrada en el post-trasplante inicial, y el desarrollo de dichas complicaciones. El grupo de Rodríguez-Perálvarez ha demostrado que tanto los niveles de Tac mayores de 10 ng/mL durante los primeros 15 días post-TH como la presencia de p…

tumores de novoinsuficiencia renalresultados a largo plazotrasplante hepáticoeventos cardiovascularesUNESCO::CIENCIAS MÉDICASmortalidadinmunosupresión:CIENCIAS MÉDICAS [UNESCO]recurrencia carcinoma hepatocelular
researchProduct

Outcome Analysis From a Multicenter Registry on Unibody Stent-Graft System for the Treatment of Spontaneous Infrarenal Acute Aortic Syndrome (MURUSSI…

2022

Purpose: This study reports the outcomes from a Multicenter Registry on unibody stent-graft system for the treatment of spontaneous infrarenal acute aortic syndrome (MURUSSIAS registry). Materials and methods: The retrospective MURUSSIAS registry included spontaneous infrarenal acute aortic dissection (IAAS) managed with the unibody stent-graft system (AFX endovascular AAA system; Endologix Inc., Irvine, California) outside the current instruction for use. IAAS considered aortic dissection (AD), intramural hematoma (IMH), and penetrating aortic ulcer (PAU). Indications to IAAS treatment were symptoms, associated dilated abdominal aorta (>3 cm), rapidly-growing (>0.5 cm/6 months) aorta…

unibody stent-graftacute aortic syndromepenetrating aortic ulcerRadiology Nuclear Medicine and imagingSurgeryaortic dissectionCardiology and Cardiovascular Medicineintramural hematoma
researchProduct

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2020

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

unstable anginaMyocardial ischaemia[SDV]Life Sciences [q-bio]Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]dual antithrombotic therapyGuidelineheparin030204 cardiovascular system & hematologyPlatelet inhibitionantiplatelet0302 clinical medicineST segmentMedicinedabigatranMyocardial infarctionguidelinesglycoprotein iib/iiia inhibitorsanticoagulationNon-ST Elevated Myocardial InfarctionrivaroxabanComputingMilieux_MISCELLANEOUSreproductive and urinary physiologydiabetesbleedingsbivalirudinatherothrombosiDisease ManagementangioplastyGuidelines • acute cardiac care • acute coronary syndrome • angioplasty • anticoagulation • antiplatelet • apixaban • aspirin • atherothrombosis • betablockers • bleedings • bivalirudin • bypass surgery • cangrelor • chest pain unit • clopidogrel • dabigatran • diabetes • dual antithrombotic therapy • early invasive strategy • edoxaban • enoxaparin • European Society of Cardiology • fondaparinux • glycoprotein IIb/ IIIa inhibitors • heparin • high-sensitivity troponin • minoca • myocardial ischaemia • myocardial infarction • nitrates • non-ST-elevation myocardial infarction • platelet inhibition • prasugrel • recommendations • revascularization • rhythm monitoring • rivaroxaban • stent • ticagrelor • triple therapy • unstable anginaenoxaparinGeneral MedicineClopidogrel3. Good healthearly invasive strategymyocardial infarctiontriple therapy030220 oncology & carcinogenesisHigh sensitivity troponinembryonic structuresCardiologyPlatelet aggregation inhibitorrevascularizationbiological phenomena cell phenomena and immunityCardiology and Cardiovascular MedicineTicagrelormedicine.drugHumanrecommendationAcute coronary syndromemedicine.medical_specialtyaspiringlycoprotein IIb/IIIa inhibitornon-ST-elevation myocardial infarctionapixabanrhythm monitoringEuropean Society of Cardiologyticagrelor03 medical and health sciencesnitrateatherothrombosisbetablockersInternal medicineacute cardiac careminocachest pain unitDiseases of the circulatory (Cardiovascular) systemHumansIn patientAcute Coronary SyndromeclopidogrelUnstable anginaurogenital systemnitratesbusiness.industryfondaparinuxbetablockerArrhythmias Cardiac030229 sport sciencesbleedingmedicine.diseasemyocardial ischaemiaplatelet inhibitionprasugreldiabeteGlycoprotein IIb/IIIa inhibitorsRC666-701bypass surgerySettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARErecommendationsedoxabanhigh-sensitivity troponinstentbusinessPlatelet Aggregation Inhibitorscangrelor
researchProduct

Comparison of inter-trial recovery times for the determination of critical power and W' in cycling

2017

Critical Power (CP) and W’ are often determined using multi-day testing protocols. To investigate this cumbersome testing method, the purpose of this study was to compare the differences between the conventional use of a 24-h inter-trial recovery time with those of 3 h and 30 min for the determination of CP and W’. Methods: 9 moderately trained cyclists performed an incremental test to exhaustion to establish the power output associated with the maximum oxygen uptake (p V O2max), and 3 protocols requiring time-to-exhaustion trials at a constant work-rate performed at 80%, 100% and 105% of p VO2max. Design: Protocol A utilised 24-h inter-trial recovery (CP24/W’24), protocol B utilised 3-h in…

validityTime FactorsTime Factorpower-duration relationshipPhysical Therapy Sports Therapy and RehabilitationAthletic Performance030204 cardiovascular system & hematology03 medical and health sciencesRecovery periodOxygen Consumption0302 clinical medicineAnimal scienceTesting protocolsHumansOrthopedics and Sports MedicinePower outputSimulationMathematicsexercise testingLimits of agreementVO2 max030229 sport sciencesQPIncremental testBicyclinganaerobic work capacityCritical intensityMuscle FatigueCritical powerExercise TestCyclingGVHuman
researchProduct

Can structural and bioactivity gradients mitigate intima hyperplasia on a small diameter tissue-engineered vascular graft?

vascular graftBiomimetictissue-engineeredCardiovascular
researchProduct

Valor pronóstico de los cambios en la rigidez arterial en la hipertensión arterial esencial

2020

INTRODUCCIÓN: La evaluación del daño orgánico subclínico, incluyendo la velocidad de la onda del pulso (VOP), podría ayudar a mejorar la estratificación del riesgo en la hipertensión arterial (HTA), especialmente en pacientes de riesgo intermedio. Sin embargo, no se dispone de información suficiente acerca de la posible relación de otros parámetros de rigidez vascular (incluyendo el echo-tracking o el índice de aumento del pulso) con el desarrollo de daño orgánico subclínico o de eventos cardiovasculares (CVs), ni tampoco para la integración de diversos parámetros. Ayudar a precisar mejor cual es la utilidad, interpretación y el mejor uso de estas herramientas de evaluación de rigidez vascu…

velocidad onda pulsocardiovascularrigidezUNESCO::CIENCIAS MÉDICAShipertensión:CIENCIAS MÉDICAS [UNESCO]arterial
researchProduct

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

2019

Background. Management of venous thromboembolism (VTE) in patients with haematologic malignancies and thrombocytopenia is clinically challenging due to the related risks. No prospective studies or clinical trials have been carried out and, therefore, no solid evidence on this compelling issue is available. Methods. Given this, an expert panel endorsed by the Gruppo Italiano Malattie Ematologiche dell'Adulto Working Party on Thrombosis and Haemostasis was set up to produce a formal consensus, according to the RAND method, in order to issue clinical recommendations about the platelet (PLT) cut-off for safe administration of low molecular weight heparin (LMWH) in thrombocytopenic (PLT <100×…

venous thrombosis thrombocytopenia blood cancer anticoagulant treatment consensusanticoagulantsblood cancerblood plateletsvenous thromboembolismthrombocytopeniaHeparin Low-Molecular-Weightheparinplatelet countanticoagulant treatmentSettore MED/15 - MALATTIE DEL SANGUEVenous thromboembolism haematological malignancythrombocytopeniaconsensuslow-molecular-weightOriginal Articlehematologic neoplasmscardiovascular diseasesvenous thrombosishumansanticoagulant treatment; blood cancer; consensus; thrombocytopenia; venous thrombosis; anticoagulants; blood platelets; heparin low-molecular-weight; humans; platelet count; consensus; hematologic neoplasms; thrombocytopenia; venous thromboembolismAnticoagulant treatment; Blood cancer; Consensus; Thrombocytopenia; Venous thrombosis
researchProduct

Effects of progressive aquatic resistance training on symptoms and quality of life in women with knee osteoarthritis: A secondary analysis.

2020

Abstract Objective: To conduct a secondary analysis to study the effects, those 4 months of aquatic resistance training have on self‐assessed symptoms and quality of life in post‐menopausal women with mild knee osteoarthritis (OA), after the intervention and after a 12‐month follow‐up period. Methods: A total of 87 post‐menopausal volunteer women, aged 60‐68 years, with mild knee OA were recruited in a randomized, controlled, 4‐month aquatic training trial (RCT) and randomly assigned to an intervention (n = 43) and a control (n = 44) group. The intervention group participated in 48 supervised aquatic resistance training sessions over 4 months while the control group maintained their usual l…

vesiliikuntaOsteoarthritis030204 cardiovascular system & hematologyGUIDELINESlaw.invention0302 clinical medicineSwimming PoolsRandomized controlled trialQuality of lifelawSecondary analysisSurveys and QuestionnairesMedicineOrthopedics and Sports Medicine315 Sport and fitness sciences4-MONTHVolunteerPain MeasurementOUTCOMESaquatic resistance trainingfollow‐up studyfollow-up studyRANDOMIZED CONTROLLED-TRIALMiddle AgedOsteoarthritis KneePostmenopauseWOMACFemaleseurantatutkimusLANDnivelrikkomedicine.medical_specialtyWOMACEXERCISEPhysical Therapy Sports Therapy and Rehabilitation03 medical and health sciencesCARTILAGEIntervention (counseling)HumansAgedbusiness.industryResistance trainingResistance Training030229 sport sciencesEFFICACYmedicine.diseaseosteoarthritisrandomized controlled trialPhysical therapyQuality of Lifebusinessrandomised controlled trialScandinavian journal of medicinescience in sportsREFERENCES
researchProduct

IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection

2021

The renal involvement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported. The etiology of kidney injury appears to be tubular, mainly due to the expression of angiotensin-converting enzyme 2, the key joint receptor for SARS-CoV-2; however, cases with glomerular implication have also been documented. The multifactorial origin of this renal involvement could include virus-mediated injury, cytokine storm, angiotensin II pathway activation, complement dysregulation, hyper-coagulation, and microangiopathy. We present the renal histological findings from a patient who developed acute kidney injury and de novo nephrotic syndrome, highly suggestive of acute IgA-domina…

viruses030232 urology & nephrologylcsh:QR1-502Case Report030204 cardiovascular system & hematologylcsh:Microbiology03 medical and health sciences0302 clinical medicineVirologySuperantigenmedicinebusiness.industrySARS-CoV-2MicroangiopathyAcute kidney injuryCOVID-19Glomerulonephritismedicine.diseaseAngiotensin IIVirusCytokine release syndromeInfectious Diseasesacute kidney injuryImmunologybusinessCytokine stormNephrotic syndromeglomerulonephritis
researchProduct

Impact of using different levels of threshold-based artefact correction on the quantification of heart rate variability in three independent human co…

2020

Heart rate variability (HRV) is a non-invasive indicator of autonomic nervous system function. HRV recordings show artefacts due to technical and/or biological issues. The Kubios software is one of the most used software to process HRV recordings, offering different levels of threshold-based artefact correction (i.e., Kubios filters). The aim of the study was to analyze the impact of different Kubios filters on the quantification of HRV derived parameters from short-term recordings in three independent human cohorts. A total of 312 participants were included: 107 children with overweight/obesity (10.0 &plusmn

young adultsmedicine.medical_specialtyMiddle-aged adultslcsh:Medicine030204 cardiovascular system & hematologyOverweightStandard deviationArticle03 medical and health sciences0302 clinical medicinechildrenInternal medicinemedicineAutonomic nervous systemHeart rate variabilityChildrenbusiness.industrymiddle-aged adultsHeart rate monitorlcsh:Rautonomic nervous system030229 sport sciencesGeneral MedicineData processingAutonomic nervous systemCardiologyAnalysis of varianceKubios softwaremedicine.symptombusinessdata processingYoung adultscirculatory and respiratory physiology
researchProduct